{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:34:03Z","timestamp":1761647643769},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,1,25]],"date-time":"2009-01-25T00:00:00Z","timestamp":1232841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s11060-008-9791-2","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T08:37:40Z","timestamp":1232786260000},"page":"379-384","source":"Crossref","is-referenced-by-count":29,"title":["Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients"],"prefix":"10.1007","volume":"93","author":[{"name":"Institut Curie Breast Cancer Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Chargari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlia M.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Di\u00e9ras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Castro","family":"Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Campana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Cottu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JeanYves","family":"Pierga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Fourquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,25]]},"reference":[{"key":"9791_CR1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9440(10)61180-7","volume":"167","author":"RJ Weil","year":"2005","unstructured":"Weil RJ, Palmieri DC, Bronder JL et al (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167:913\u2013920","journal-title":"Am J Pathol"},{"key":"9791_CR2","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B","volume":"52","author":"Y Tsukada","year":"1983","unstructured":"Tsukada Y, Fouad A, Pickren JW et al (1983) Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52:2349\u20132354. doi:10.1002\/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B","journal-title":"Cancer"},{"key":"9791_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0360-3016(80)90195-9","volume":"6","author":"B Borgelt","year":"1980","unstructured":"Borgelt B, Gelber R, Kramer S et al (1980) The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1\u20139","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9791_CR4","first-page":"2948","volume":"5","author":"N Sawada","year":"1999","unstructured":"Sawada N, Ishikawa T, Sekiguchi F et al (1999) X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 5:2948\u20132953","journal-title":"Clin Cancer Res"},{"key":"9791_CR5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00000421-200108000-00026","volume":"24","author":"MLH Wang","year":"2001","unstructured":"Wang MLH, Yung WKA, Royce ME et al (2001) Capecitabine for 5-fluorouracil resistant brain metastases from breast cancer. Am J Clin Oncol 24:421\u2013424. doi: 10.1097\/00000421-200108000-00026","journal-title":"Am J Clin Oncol"},{"key":"9791_CR6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1215\/S1152851703000334","volume":"6","author":"LR Rogers","year":"2004","unstructured":"Rogers LR, Remer SE, Tejwani S (2004) Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy. Neuro-oncol 6:63\u201364. doi: 10.1215\/S1152851703000334","journal-title":"Neuro-oncol"},{"key":"9791_CR7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/B:NEON.0000003752.89814.ca","volume":"65","author":"P Giglio","year":"2003","unstructured":"Giglio P, Tremont-Lukats IW, Groves MD (2003) Response of neoplastic meningitis from solid tumors to oral capecitabine. J Neurooncol 65:167\u2013172. doi: 10.1023\/B:NEON.0000003752.89814.ca","journal-title":"J Neurooncol"},{"key":"9791_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3816\/CBC.2006.n.028","volume":"7","author":"YL Tham","year":"2006","unstructured":"Tham YL, Hinckley L, Teh BS et al (2006) Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report. Clin Breast Cancer 7:164\u2013166. doi: 10.3816\/CBC.2006.n.028","journal-title":"Clin Breast Cancer"},{"key":"9791_CR9","first-page":"833","volume":"5","author":"N Siegelmann-Danieli","year":"2003","unstructured":"Siegelmann-Danieli N, Stein M, Bar-Ziv J (2003) Complete response of brain metastases originating in breast cancer to capecitabine therapy. Isr Med Assoc J 5:833\u2013834","journal-title":"Isr Med Assoc J"},{"key":"9791_CR10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/07357900600705805","volume":"24","author":"A Fabi","year":"2006","unstructured":"Fabi A, Vidiri A, Ferretti G et al (2006) Dramatic regression of multiple brain metastases from breast cancer with capecitabine: another arrow at the bow? Cancer Invest 24:466\u2013468. doi: 10.1080\/07357900600705805","journal-title":"Cancer Invest"},{"key":"9791_CR11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0959-8049(98)00058-6","volume":"34","author":"M Miwa","year":"1998","unstructured":"Miwa M, Ura M, Nishida M et al (1998) Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34:1274\u20131281. doi: 10.1016\/S0959-8049(98)00058-6","journal-title":"Eur J Cancer"},{"key":"9791_CR12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","volume":"43","author":"L Gaspar","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 43:745\u2013751. doi: 10.1016\/S0360-3016(96)00619-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9791_CR13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0360-3016(97)00341-6","volume":"39","author":"KJ Murray","year":"1997","unstructured":"Murray KJ, Scott C, Greenberg HM et al (1997) A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 39:571\u2013574. doi: 10.1016\/S0360-3016(97)00341-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9791_CR14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1212\/WNL.39.6.789","volume":"39","author":"LM DeAngelis","year":"1989","unstructured":"DeAngelis LM, Delattre JY, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789\u2013796","journal-title":"Neurology"},{"key":"9791_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0973-1482.37409","volume":"3","author":"T Wadasadawala","year":"2007","unstructured":"Wadasadawala T, Gupta S, Bagul V, Patil N (2007) Brain metastases from breast cancer: management approach. J Cancer Res Ther 3:157\u2013165","journal-title":"J Cancer Res Ther"},{"key":"9791_CR16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.1988.6.10.1653","volume":"6","author":"HM Pinedo","year":"1988","unstructured":"Pinedo HM, Peters GF (1988) Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6:1653\u20131664","journal-title":"J Clin Oncol"},{"key":"9791_CR17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncponc0714","volume":"4","author":"TY Seiwert","year":"2007","unstructured":"Seiwert TY, Salama JK, Vokes EE (2007) The concurrent chemoradiation paradigm\u2013\u2013general principles. Nat Clin Pract Oncol 4:86\u2013100. doi: 10.1038\/ncponc0714","journal-title":"Nat Clin Pract Oncol"},{"key":"9791_CR18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1053-4296(97)80024-0","volume":"7","author":"TS Lawrence","year":"1997","unstructured":"Lawrence TS, Tepper JE, Blackstock AW (1997) Fluoropyrimidine-radiation interactions in cells and tumors. Semin Radiat Oncol 7:260\u2013266. doi: 10.1016\/S1053-4296(97)80024-0","journal-title":"Semin Radiat Oncol"},{"key":"9791_CR19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/srao.2001.26002","volume":"11","author":"CJ McGinn","year":"2001","unstructured":"McGinn CJ, Lawrence TS (2001) Recent advances in the use of radiosensitizing nucleosides. Semin Radiat Oncol 11:270\u2013280. doi: 10.1053\/srao.2001.26002","journal-title":"Semin Radiat Oncol"},{"key":"9791_CR20","unstructured":"McEvoy GK (ed) (2002) Capecitabine. In: AHFS drug information. American Society of Health-System Pharmacists, Bethesda, MD, pp 916\u2013921"},{"key":"9791_CR21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0404.1986.tb07862.x","volume":"74","author":"MS Heier","year":"1986","unstructured":"Heier MS, Heintz R, Fossa SD (1986) Passage of 50-dFUrd and its metabolites 5-FU and 5-FUH2 to CSF in a clinical phase 1 study. Acta Neurol Scand 74:240\u2013244","journal-title":"Acta Neurol Scand"},{"key":"9791_CR22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.biopha.2007.08.014","volume":"61","author":"WT Loo","year":"2007","unstructured":"Loo WT, Sasano H, Chow LW (2007) Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in\u00a0vitro. Biomed Pharmacother 61:553\u2013557. doi: 10.1016\/j.biopha.2007.08.014","journal-title":"Biomed Pharmacother"},{"key":"9791_CR23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-007-9409-0","volume":"85","author":"M Ekenel","year":"2007","unstructured":"Ekenel M, Hormigo AM, Peak S, Deangelis LM, Abrey LE (2007) Capecitabine therapy of central nervous system metastases from breast cancer. J Neurooncol 85:223\u2013227. doi: 10.1007\/s11060-007-9409-0","journal-title":"J Neurooncol"},{"key":"9791_CR24","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/cncr.22127","volume":"107","author":"E Rivera","year":"2006","unstructured":"Rivera E, Meyers C, Groves M et al (2006) Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer 107:1348\u20131354. doi: 10.1002\/cncr.22127","journal-title":"Cancer"},{"key":"9791_CR25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2407-7-18","volume":"7","author":"R Addeo","year":"2007","unstructured":"Addeo R, Caraglia M, Faiola V et al (2007) Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. BMC Cancer 7:18. doi: 10.1186\/1471-2407-7-18","journal-title":"BMC Cancer"},{"key":"9791_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/annonc\/mdl290","volume":"18","author":"A Carmona-Bayonas","year":"2007","unstructured":"Carmona-Bayonas A (2007) Concurrent radiotherapy and capecitabine, followed by high-dose methotrexate consolidation, provided effective palliation in a patient with leptomeningeal metastases from breast cancer. Ann Oncol 18:199\u2013200. doi: 10.1093\/annonc\/mdl290","journal-title":"Ann Oncol"},{"key":"9791_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.breast.2005.03.006","volume":"15","author":"H Hikino","year":"2006","unstructured":"Hikino H, Yamada T, Johbara K et al (2006) Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse. Breast 15:97\u201399. doi: 10.1016\/j.breast.2005.03.006","journal-title":"Breast"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9791-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-008-9791-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9791-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:19:26Z","timestamp":1559362766000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-008-9791-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,25]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["9791"],"URL":"https:\/\/doi.org\/10.1007\/s11060-008-9791-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2009,1,25]]}}}